Literature DB >> 21703429

Lung-residing metastatic and dormant neuroblastoma cells.

Liat Edry Botzer1, Shelly Maman, Orit Sagi-Assif, Tzipi Meshel, Ido Nevo, Tobias Bäuerle, Ilana Yron, Isaac P Witz.   

Abstract

The mechanism by which dormant tumor cells can begin growing after long periods of inactivity and accelerate disease recurrence is poorly understood. The present study characterizes dormant neuroblastoma (NB) cells, as well as metastatic cells, which reside in the same organ microenvironment. A xenograft model of human NB consisting of variants that generate nonmetastatic local tumors in the orthotopic inoculation site and variants that generate lung metastatic NB (MetNB) cells was developed in our laboratory. The present study shows that lungs of mice inoculated with nonmetastatic NB variants contain disseminated neuroblastoma (DisNB) human cells. Both DisNB and MetNB variants expressed a similar tumorigenicty phenotype in vivo, whereas the MetNB variants produced a heavy metastatic load and the DisNB variants produced no or little metastasis. A comparative in vitro characterization of MetNB and DisNB cells revealed similarities and differences. DisNB, but not MetNB cells, expressed the minimal residual disease markers PHOX2B and TH. MetNB cells demonstrated higher migratory capacity, an elevated matrix metalloproteinase (MMP) secretion, and a higher constitutive phosphorylation of extracellular signal-regulated kinase (ERK) than DisNB cells. We suggest that characteristics common to both MetNB and DisNB cells were acquired relatively early in the metastatic process and the characteristics that differ between these variants were acquired later. We hypothesize that the DisNB cells are metastasis precursors, which may progress toward metastasis under certain microenvironmental conditions.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703429      PMCID: PMC3123856          DOI: 10.1016/j.ajpath.2011.03.020

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.

Authors:  George N Naumov; Ian C MacDonald; Pascal M Weinmeister; Nancy Kerkvliet; Kishore V Nadkarni; Sylvia M Wilson; Vincent L Morris; Alan C Groom; Ann F Chambers
Journal:  Cancer Res       Date:  2002-04-01       Impact factor: 12.701

2.  Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.

Authors:  Tatsuo Kuroda; Nobuyuki Morikawa; Kentaro Matsuoka; Akihiro Fujino; Toshiro Honna; Atsuko Nakagawa; Masaaki Kumagai; Hidekazu Masaki; Morihiro Saeki
Journal:  J Pediatr Surg       Date:  2008-12       Impact factor: 2.545

Review 3.  Circulating tumor cells and bone marrow micrometastasis.

Authors:  Catherine Alix-Panabières; Sabine Riethdorf; Klaus Pantel
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

4.  Generation and characterization of novel local and metastatic human neuroblastoma variants.

Authors:  Ido Nevo; Orit Sagi-Assif; Liat Edry Botzer; Dana Amar; Shelly Maman; Naam Kariv; Leonor E Leider-Trejo; Larissa Savelyeva; Manfred Schwab; Ilana Yron; Isaac P Witz
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

5.  Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.

Authors:  Qiang-Song Tong; Li-Duan Zheng; Shao-Tao Tang; Qing-Lan Ruan; Yuan Liu; Shi-Wang Li; Guo-Song Jiang; Jia-Bin Cai
Journal:  World J Pediatr       Date:  2008-02       Impact factor: 2.764

6.  CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow.

Authors:  Irma Airoldi; Claudia Cocco; Fabio Morandi; Ignazia Prigione; Vito Pistoia
Journal:  Cancer Immunol Immunother       Date:  2007-09-05       Impact factor: 6.968

Review 7.  Cancer stem cells: markers or biomarkers?

Authors:  Wendy A Woodward; Erik P Sulman
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

8.  PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.

Authors:  Janine Stutterheim; Annemieke Gerritsen; Lily Zappeij-Kannegieter; Ilona Kleijn; Rob Dee; Lotty Hooft; Max M van Noesel; Marc Bierings; Frank Berthold; Rogier Versteeg; Huib N Caron; C Ellen van der Schoot; Godelieve A M Tytgat
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

Review 9.  Review: Biological relevance of disseminated tumor cells in cancer patients.

Authors:  Sabine Riethdorf; Harriet Wikman; Klaus Pantel
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

10.  The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.

Authors:  Ido Nevo; Orit Sagi-Assif; Tsipi Meshel; Adit Ben-Baruch; Karin Jöhrer; Richard Greil; Leonor E Leider Trejo; Oleg Kharenko; Meora Feinmesser; Ilana Yron; Isaac P Witz
Journal:  Cancer Lett       Date:  2008-09-07       Impact factor: 8.679

View more
  7 in total

1.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

2.  Hexokinase 2 is a determinant of neuroblastoma metastasis.

Authors:  Liat Edry Botzer; Shelly Maman; Orit Sagi-Assif; Tsipi Meshel; Ido Nevo; Ilana Yron; Isaac P Witz
Journal:  Br J Cancer       Date:  2016-03-17       Impact factor: 7.640

3.  Chronic radiation exposure of neuroblastoma cells reduces nMYC copy number.

Authors:  Manu Gnanamony; Reuben Antony; Karen S Fernández; Libes Jaime; Julian Lin; Pushpa A Joseph; Christopher S Gondi
Journal:  Oncol Lett       Date:  2017-07-21       Impact factor: 2.967

4.  PHOX2B is a suppressor of neuroblastoma metastasis.

Authors:  Osnat Naftali; Shelly Maman; Tsipi Meshel; Orit Sagi-Assif; Ravit Ginat; Isaac P Witz
Journal:  Oncotarget       Date:  2016-03-01

5.  Differential Proteome Analysis of Human Neuroblastoma Xenograft Primary Tumors and Matched Spontaneous Distant Metastases.

Authors:  Lorena Hänel; Tobias Gosau; Hanna Maar; Ursula Valentiner; Udo Schumacher; Kristoffer Riecken; Sabine Windhorst; Nils-Owe Hansen; Laura Heikaus; Marcus Wurlitzer; Ingo Nolte; Hartmut Schlüter; Tobias Lange
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

Review 6.  Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment.

Authors:  Sivan Izraely; Isaac P Witz
Journal:  Int J Cancer       Date:  2020-08-27       Impact factor: 7.396

Review 7.  Cancer Cell Dormancy in Metastasis.

Authors:  Matthew A Summers; Michelle M McDonald; Peter I Croucher
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.